 |
南京科佰生物科技有限公司
主營產(chǎn)品： atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫購買 |
員.png)
11
聯(lián)系電話
|
南京科佰生物科技有限公司
主營產(chǎn)品： atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫購買 |
聯(lián)系電話
| 參考價(jià) | 面議 |
更新時(shí)間：2023-05-15 09:20:06瀏覽次數(shù)：1260
聯(lián)系我們時(shí)請說明是化工儀器網(wǎng)上看到的信息,，謝謝!
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | T-25 Flask |
|---|---|---|---|
| 貨號 | CBP73377 | 應(yīng)用領(lǐng)域 | 生物產(chǎn)業(yè) |
| CBP73377 | |
| I. Introduction | |
Cell Line Name： | FGFR3-TACC3 [K650N] /BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
FGFR3-TACC3 results from the fusion of FGFR3 and TACC3, demonstrating constitutive kinase activity, transforming activity in culture and ability to drive tumor growth in xenografts (PMID: 25294908, PMID: 22837387). FGFR3-TACC3 has been identified in lung adenocarcinoma and glioblastoma (PMID: 25294908, PMID: 22837387). | |
| III. Representative Data | |
1.WB of FGFR3-TACC3 [K650N] /BaF3
| |
2. Sanger of FGFR3-TACC3 [K650N] /BaF3
Figure 2. FGFR3-TACC3 [K650N] /BaF3 K650N
Figure 3. FGFR3-TACC3 [K650N] /BaF3 FGFR3-TACC3 | |
3. Anti-proliferation assay
Figure 4. CTG Proliferation Assay of BaF3 FGFR3-TACC3 K650N Cells (C3). | |
![CBP73377 sanger-K650N [K650N]FGFR3-TACC3 Baf3.jpg](https://img69.chem17.com/33c3386a40defc475760f2d932f284033cb8b6e22f4d3332c99606fa20a5b6639ca17b0d7b44af91.jpg "CBP73377 sanger-K650N [K650N]FGFR3-TACC3 Baf3.jpg")
